Humana (HUM): Today's Featured Health Services Loser

Humana ( HUM) pushed the Health Services industry lower today making it today's featured Health Services loser. The industry as a whole closed the day up 0.2%. By the end of trading, Humana fell $1.34 (-1.8%) to $74.50 on average volume. Throughout the day, 2.2 million shares of Humana exchanged hands as compared to its average daily volume of 1.8 million shares. The stock ranged in price between $74.38-$75.90 after having opened the day at $75.75 as compared to the previous trading day's close of $75.84. Other company's within the Health Services industry that declined today were: Sunshine Heart ( SSH), down 14.2%, Urologix ( ULGX), down 8%, Dynatronics Corporation ( DYNT), down 7.8%, and Foundation SunLink Healthcare Affiliates In ( SSY), down 7.1%.

Humana Inc. operates as a health care company that offers a range of insurance products and health and wellness services that incorporate an integrated approach to lifelong well-being. Humana has a market cap of $12.45 billion and is part of the health care sector. The company has a P/E ratio of 9.5, equal to the average health services industry P/E ratio and below the S&P 500 P/E ratio of 17.7. Shares are down 12.9% year to date as of the close of trading on Tuesday. Currently there are 14 analysts that rate Humana a buy, no analysts rate it a sell, and eight rate it a hold.

TheStreet Ratings rates Humana as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels, good cash flow from operations and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the positive front, Stereotaxis ( STXS), up 16.4%, IsoRay ( ISR), up 10.6%, EnteroMedics ( ETRM), up 9.3%, and Misonix ( MSON), up 9.1%, were all gainers within the health services industry with Thermo Fisher Scientific ( TMO) being today's featured health services industry winner.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

If you liked this article you might like

Apple Is the Tom Brady of Stocks: Cramer's 'Mad Money' Recap (Thursday 8/31/17)

Boeing, Pure Storage, Activision Blizzard: 'Mad Money' Lightning Round

The Makings of Another Huge Rebound?

Healthcare Management Stocks Look Too Pricey for Activists

Tenet Dives After Worse Than Expected Quarter Leads to Lower 2017 Outlook